JP2010517955A5 - - Google Patents

Download PDF

Info

Publication number
JP2010517955A5
JP2010517955A5 JP2009547651A JP2009547651A JP2010517955A5 JP 2010517955 A5 JP2010517955 A5 JP 2010517955A5 JP 2009547651 A JP2009547651 A JP 2009547651A JP 2009547651 A JP2009547651 A JP 2009547651A JP 2010517955 A5 JP2010517955 A5 JP 2010517955A5
Authority
JP
Japan
Prior art keywords
ono
formula
group
linear
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009547651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010517955A (ja
JP5216782B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/050938 external-priority patent/WO2008095806A1/en
Publication of JP2010517955A publication Critical patent/JP2010517955A/ja
Publication of JP2010517955A5 publication Critical patent/JP2010517955A5/ja
Application granted granted Critical
Publication of JP5216782B2 publication Critical patent/JP5216782B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009547651A 2007-02-05 2008-01-28 酸化窒素放出性ステロイド Expired - Fee Related JP5216782B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US89937607P 2007-02-05 2007-02-05
US60/899,376 2007-02-05
US92945607P 2007-06-28 2007-06-28
US60/929,456 2007-06-28
PCT/EP2008/050938 WO2008095806A1 (en) 2007-02-05 2008-01-28 Nitric oxide releasing steroids

Publications (3)

Publication Number Publication Date
JP2010517955A JP2010517955A (ja) 2010-05-27
JP2010517955A5 true JP2010517955A5 (enExample) 2011-03-17
JP5216782B2 JP5216782B2 (ja) 2013-06-19

Family

ID=39232800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009547651A Expired - Fee Related JP5216782B2 (ja) 2007-02-05 2008-01-28 酸化窒素放出性ステロイド

Country Status (15)

Country Link
US (4) US8933062B2 (enExample)
EP (3) EP2109617A1 (enExample)
JP (1) JP5216782B2 (enExample)
KR (1) KR20090107525A (enExample)
CN (1) CN101652380A (enExample)
AU (1) AU2008213046B2 (enExample)
BR (1) BRPI0807078A2 (enExample)
CA (3) CA2677441C (enExample)
ES (1) ES2601102T3 (enExample)
IL (1) IL199815A (enExample)
MX (1) MX2009008334A (enExample)
NZ (1) NZ579067A (enExample)
RU (1) RU2442790C2 (enExample)
WO (3) WO2008095809A1 (enExample)
ZA (1) ZA200905067B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011243947A1 (en) 2010-04-23 2012-12-06 Piramal Enterprises Limited Nitric oxide releasing prodrugs of therapeutic agents
US8846723B2 (en) 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
KR20140103099A (ko) 2011-10-12 2014-08-25 아센디스 파마 옵탈몰로지 디비젼 에이/에스 안구 병태의 예방 및 치료
EP2729220B1 (en) * 2011-12-20 2015-11-04 Oriflame Research and Development Ltd. Compounds with anti-aging activities
WO2014056915A1 (en) 2012-10-11 2014-04-17 Ascendis Pharma A/S Diagnosis, prevention and treatment of diseases of the joint
CA2897571C (en) 2013-01-21 2018-12-18 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group
RU2545416C1 (ru) * 2014-02-18 2015-03-27 Ксения Юрьевна Еременко Способ лечения возрастной макулярной дистрофии
CN103880907A (zh) * 2014-03-11 2014-06-25 天津金耀集团有限公司 丁酸氢化可的松半水合物
AU2017359043B2 (en) 2016-11-08 2022-06-16 Regeneron Pharmaceuticals, Inc. Steroids and protein-conjugates thereof
KR20200007905A (ko) 2017-05-18 2020-01-22 리제너론 파마슈티칼스 인코포레이티드 사이클로덱스트린 단백질 약물 접합체
CA3080857A1 (en) 2017-11-07 2019-05-16 Regeneron Pharmaceuticals, Inc. Hydrophilic linkers for antibody drug conjugates
EA202091672A1 (ru) 2018-01-08 2021-02-01 Регенерон Фармасьютикалз, Инк. Стероиды и их антитело-конъюгаты
WO2019217591A1 (en) 2018-05-09 2019-11-14 Regeneron Pharmaceuticals, Inc. Anti-msr1 antibodies and methods of use thereof
WO2020047496A1 (en) * 2018-08-31 2020-03-05 Aerie Pharmaceuticals, Inc. Isoquinoline-steroid conjugates and uses thereof
WO2022135332A1 (zh) * 2020-12-21 2022-06-30 映恩生物制药(苏州)有限公司 一种甾体偶联物
JP7687973B2 (ja) * 2022-01-24 2025-06-03 芳弘 二村 フィブロネクチン活性化作用を介した表皮細胞増殖作用を呈するジテルペン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183252A (en) 1963-09-05 1965-05-11 Syntex Corp 16-nitratoalkyl-pregnanes
US3494941A (en) * 1967-12-04 1970-02-10 American Home Prod Nitrate esters of 17beta-(hydroxyalkoxy)steroid 3-ols,3-ones and 3-amidinohydrazones
HU164115B (enExample) 1971-05-07 1973-12-28
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
IT1311922B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
AU2006286838C1 (en) * 2005-09-02 2013-05-02 Ferrer Internacional S.A. Nitrooxy derivatives of glucocorticoids

Similar Documents

Publication Publication Date Title
JP2010517955A5 (enExample)
CN100469765C (zh) 前列腺素硝基氧衍生物
JP2022081661A5 (enExample)
JP2009504763A5 (enExample)
RU2008143668A (ru) Производное инсулина
JP2006515838A5 (enExample)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
RU2010116708A (ru) Бициклическое производное гамма-аминокислоты
JP2007510662A5 (enExample)
ES2437346T3 (es) Procedimiento para la producción de derivado de diamina
WO2019131580A1 (ja) カチオン性脂質
JP2006507220A5 (enExample)
JP2004517098A5 (enExample)
JP2011519360A5 (enExample)
JP2006504738A5 (enExample)
RU2374228C2 (ru) Производные 4-фенилпиперидина в качестве ингибиторов ренина
JP2011157375A (ja) 共有結合した酸を有するアシマドリンの誘導体
JP2005526138A5 (enExample)
JP2009525970A5 (enExample)
JP2005514440A5 (enExample)
JP5341521B2 (ja) タンパク質と結合パートナーとの相互作用を阻害するための化合物及び方法
JP2008542386A5 (enExample)
WO2020041344A4 (en) Methods and compositions for drugs to treat ophthalmic diseases
CN1077790C (zh) 青光眼治疗剂及眼压降低剂
ES2643377T3 (es) Composición farmacéutica para prevenir o tratar degeneración macular